SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-2.88%
↑ 98% above average
Average (39q)
-117.39%
Historical baseline
Range
High:132.67%
Low:-4494.14%
CAGR
-2.9%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -2.88% |
| Q2 2025 | -13.56% |
| Q1 2025 | 13.72% |
| Q4 2024 | 5.22% |
| Q3 2024 | 4.85% |
| Q2 2024 | 21.91% |
| Q1 2024 | -17.58% |
| Q4 2023 | 12.20% |
| Q3 2023 | -4.83% |
| Q2 2023 | 20.34% |
| Q1 2023 | -21.66% |
| Q4 2022 | -29.89% |
| Q3 2022 | 16.54% |
| Q2 2022 | 49.75% |
| Q1 2022 | -153.77% |
| Q4 2021 | 6.87% |
| Q3 2021 | -53.59% |
| Q2 2021 | -91.97% |
| Q1 2021 | 35.33% |
| Q4 2020 | 16.92% |
| Q3 2020 | -1.08% |
| Q2 2020 | -6.81% |
| Q1 2020 | 44.16% |
| Q4 2019 | -76.56% |
| Q3 2019 | -34.08% |
| Q2 2019 | 30.92% |
| Q1 2019 | 65.95% |
| Q4 2018 | -4494.14% |
| Q3 2018 | 95.22% |
| Q2 2018 | 24.18% |
| Q1 2018 | 2.23% |
| Q4 2017 | -34.60% |
| Q3 2017 | 27.71% |
| Q2 2017 | 28.28% |
| Q1 2017 | -112.44% |
| Q4 2016 | 20.39% |
| Q3 2016 | -228.58% |
| Q2 2016 | 132.67% |
| Q1 2016 | 16.19% |
| Q4 2015 | -9.16% |